Bio Ventures For Global Health

Nonprofit profile at a glance

EIN
300213137
IRS 990 coverage
2011–2024
Forms available
Form 990 2024
Location
Seattle, WA, USA
Phone
2068807778
Rating
80
Verdict
STRONG
Rating confidence
Moderate
Sector
Fund Raising and/or Fund Distribution

Official website

Reported finances

Revenue
$504,858
Expenses
$2,591,563
Assets
$5,351,162
Liabilities
$298,053

Source: IRS Form 990. Selected filing: tax year 2024. Amounts in USD.

Leadership & pay

11 people listed

Executive titles in this filing

  • Jennifer Dent (President & CEO)
  • Katy Graef (Vice President Programs)
  • Cathyryne Manner (Vice President)

Highest reported compensation

  • Jennifer Dent (President & CEO): $486,109 total reported compensation
  • Katy Graef (Vice President Programs): $208,226 total reported compensation
  • Cathyryne Manner (Vice President): $188,815 total reported compensation

Source: IRS Form 990. Selected filing: tax year 2024. Names and roles reflect this filing, not necessarily current officeholders.

Overview

Mission

BVGH drives sustainable, market-informed solutions to improve access to quality healthcare in low- and middle-income countries. BVGH builds cross-sector partnerships that align industry, government, and local health-system priorities to expand access to cancer care, infectious disease technologies, and essential medicines. BVGHs flagship programs focus on strengthening cancer and infectious disease ecosystems through coordinated national strategies, capacity building, and responsible product introduction. Key activities include the African Access Initiative (AAI), which supports countries in developing cancer control plans, expanding diagnostics and treatment capacity, and improving affordability and availability of oncology products. BVGH also brokers collaborations between companies and African research institutions to advance R&D, clinical trials, workforce training, and technology transfer. These activities collectively enhance health-system readiness, accelerate access to lifesavi

What it reported doing in 2024

BVGH Infectious Disease Programs (Global Innovation Alliance (GIA) and Global Innovation Alliance Network of Trial Sites (GIANTS)): BVGH catalyzes and manages global cross-organization, cross-sector collaborations to advance research and development (R&D) targeting infectious diseases with high burdens in LMICs. Through the Global Innovation Alliance (GIA), BVGH: 1.) builds and manages R&D collaborations between LMIC scientists and global partners; 2.) assesses, promotes, and fosters clinical trial capacity and inclusion in LMICs; 3.) elevates scientific expertise in LMICs through tailored capacity building programs; and 4.) evaluates and communicates program outcomes and impacts to broad and targeted global audiences. The programs strengthen laboratory capacity, support technology transfer, and advance co-developed R&D initiatives for vaccines, therapeutics, and diagnostics. By integrating country-level health system knowledge with real-world implementation data, BVGH helps partners accelerate innovation and prepare for feasible adoption pathways. This work contributes to more resilient infectious disease response systems and informed policy decision-making.

Operating model

Revenue model
Donor-supported. 100% of the money available for current operations came from contributions and gifts.
Distribution model
Direct operator. The filing allocates 100% of reported program-service expenses outside its grant, affiliate-payment, and member-benefit lines. This expense classification does not rule out separately announced grant awards.

The verdict

STRONG - A large share of available resources goes toward mission work and the filed numbers largely add up. Fundraising costs are high for each dollar raised and expenses are high relative to revenue.

Rating breakdown

  • Financial Efficiency: 79
  • Transparency & Controls: 80
  • Accountability: 89
  • Sustainability: 26
  • Growth: 100

Detailed rating inputs

Financial Efficiency

  • Mission deployment rate: 100%; rating input score 100
  • Program expense ratio: 69.7%; rating input score 70
  • Fundraising efficiency: $1.06 raised per $1 spent on fundraising; rating input score 3; 3rd percentile among comparable filings

Transparency & Controls

  • Consistency checks: 92.3%; rating input score 92; 16th percentile among comparable filings
  • Pay-setting controls: 4 of 6 controls in place; rating input score 67
    • Compensation committee: Pass
    • Independent consultant: Pass
    • Other Form 990s reviewed: Missing
    • Written employment contract: Pass
    • Compensation survey or study: Missing
    • Board or committee approval: Pass
  • Foreign activity oversight: Limited
  • Grant itemization coverage: Limited
  • Major donor itemization: Yes; rating input score 100
  • Related-party transparency: Limited

Accountability

  • Independent voting board: 88.9%; rating input score 89; 22nd percentile among comparable filings
  • Governance controls: 7 of 8 controls in place; rating input score 88
    • Conflict-of-interest policy: Pass
    • Whistleblower policy: Pass
    • Document-retention policy: Pass
    • CEO compensation review process: Pass
    • Other executive compensation review process: NotApplicable
    • Form 990 shared with the board: Pass
    • Board meeting minutes documented: Pass
    • Audit committee oversight: Pass
    • Independent financial-statement audit: Fail

Sustainability

  • Operating margin: -413.3%; rating input score 0; 0th percentile among comparable filings
  • Total-asset coverage ratio: 2.06; rating input score 66; 66th percentile among comparable filings
  • Liabilities to assets ratio: 0.06; rating input score 51; 51st percentile among comparable filings
  • Officer compensation ratio: 34.1%; rating input score 5; 5th percentile among comparable filings

Growth

  • Program expense growth: 4.7% per year; rating input score 100; 40th percentile among comparable filings
  • Revenue growth: 2.6% per year; rating input score 100; 28th percentile among comparable filings
  • Asset growth: 15.4% per year; rating input score 100; 73rd percentile among comparable filings

Details

  • Where the money goes: 100% of revenue deployed · 69.7% of spending went to programs
  • Governance: 8 of 9 board members independent · 7 of 8 filing controls reported
  • Programs: 3 filed program accomplishments · $1.8M in reported program spending
  • Leadership: top reported pay $486K · 11 people listed · 4 of 6 pay-setting controls reported
  • Consistency: 28 of 28 current checks pass
  • Schedules: 5 filed schedules · includes major donors and executive pay
  • Filing history: 12 filing years from 2011 to 2024
  • Contacts: How to reach this organization
  • Money network: 3 filed money-flow records
  • Related organizations: Filed and resolved organization relationships.
  • Grant readiness: Federal tax and exclusion status, award history, and grant-maker relationships.
  • People: Everyone the filings name, and which of them the filings identify by more than a name.

Key Signals

Signals prioritize questions for review. They are not findings of misconduct.

  • High — Financial Efficiency: Fundraising efficiency scored 3/100.
  • High — Sustainability: Operating margin scored 0/100.
  • Review — Accountability: Governance controls: Independent financial-statement audit not reported.
  • High — Sustainability: Officer compensation ratio scored 5/100.
  • Review — Sustainability: Liabilities to assets ratio scored 51/100.